Bergua Burgués, Juan Miguel | Hematología y Hemoterapia |

Resultados: 242
Tipo Título / Nombre Autor(es) Año
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial Ribera JM, Morgades M, Garcia-Calduch O, Sirvent M, Buendia B..., Bergua JM 2024
Outcomes after intensive chemotherapy for secondary and myeloidrelated changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M..., Bergua J 2024
Clinical Features and Treatment in Patients Diagnosed with Blastic Plasmacytoid Dendritic Cell Neoplasm: Interim Analysis from the Pethema Epidemiologic Registry (EPI-BLAS study) Navarro Vicente I, Lloret Madrid P, Solana Altabella A..., Bergua Burgues JM 2023
LOTIS-5, an ongoing phase 3 randomized study of Loncastuximab Tesirine with Rituximab (Lonca-r) versus immunochemotherapy in patients with R/R DLBCL Carlo-Stella C, Kwiatek M, Chung M, Móciková H, Bergua-Burgues JM, Gao S, Grosicki S, Stathis A, Toupin D, Wang Y, Wang L, Hamadani M 2023
Incidence, risk factors and outcomes od second neoplasm in patients with acute promyelocytic leukemia: the PETHEMA -PALG experience Sobas M, Knopinska-Posluszny W, Pi?tkowska-Jakubas B..., Bergua Burgues JM 2023
AML-443 Clonal Evolution Analysis Using Next Generation Sequencing (NGS) Panel in a Cohort of 3,025 Patients With Acute Myeloid Leukemia (AML) Colmenares R, Sargas C..., Bergua Burgues JM 2023
FLT3-ITP mutation characterization with classical PCR methodology versus capture and amplicon based NGS platforms: a PETHEMA NGS-AML project Bilbao C, Stuckey R..., Bergua Burgues JM 2023
Safety and efficacy of LP-108 as monotherapy and combined with azacitidine in patients with relapsed/refractory myelodysplastic syndromes, chronic myelomonocytic leukemia, or acute myeloid leukemia Koenig K, Bergua Burgues JM, Montesinos P..., Curran E 2023
Covalent Menin Inhibitor Bmf-219 in Patients with Relapsed or Refractory (R/R) Acute Leukemia (AL): Preliminary Phase 1 Data from the Covalent-101 Study Lancet J, Ravandi F, Monteseinos P..., Bergua Burgues JM 2023
Data-Driven Multiparameter Flow Cytometry (MFC) Classification of Blast Differentiation in Elderly Patients with Acute Myeloid Leukemia (AML) González C, Simoes, Ariceta B, Martínez-Cuadron D..., Bergua Burgues JM 2023